top of page

AF710B, a Concomitant Activator of M1 Muscarinic and Sigma-1 Receptors: Possibly Disease-Modifying

  • Writer: ANAVEX® Life Sciences Corp.
    ANAVEX® Life Sciences Corp.
  • Mar 13, 2016
  • 1 min read

14th International Symposium on Advances in Alzheimer Therapy, Athens, Greece

Hall, Hélène; Iulita, M. Florencia; Ducatenzeiler, Adriana; Fisher, Abraham & Cuello, A. Claudio


 
 
bottom of page